(Reuters) - Inscripta said on Wednesday it raised $55.5 million in funding as the privately held biotech startup looks to strengthen its research team and speed up development and commercialization efforts of its gene-editing tools.
from Reuters: Technology News http://ift.tt/2CNsMeH
0 comments:
Post a Comment